NCT05476224View on ClinicalTrials.gov

Qualitative and Functional Investigation of Lipids in Patients With SARS-CoV2 Infection - In Search of Atherogenic Sequelae

CompletedOBSERVATIONAL

Enrollment

228

Participants

Timeline

Start Date

June 14, 2022

Primary Completion Date

April 12, 2023

Study Completion Date

April 12, 2023

Conditions

SARS-CoV2 Infection

Interventions

BIOLOGICAL

Blood sample of 30 ml

The parameters analyzed on this blood sample: Fasting blood glucose, HbA1C, creatinine, creatinine clearance (MDRD), fasting lipid profile (total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides.

Trial Locations (1)

Unknown

Chu Dijon Bourgogne, Dijon

All Listed Sponsors

lead

Centre Hospitalier Universitaire Dijon

OTHER